232 related articles for article (PubMed ID: 18685506)
21. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
Reid G; Beuerman D; Heinemann C; Bruce AW
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):37-41. PubMed ID: 11750220
[TBL] [Abstract][Full Text] [Related]
22. [Effect of oral
Liu Y; Huang Y; Cai W; Li D; Zheng W; Xiao Y; Liu Y; Zhao H; Pan S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1753-1759. PubMed ID: 33380389
[TBL] [Abstract][Full Text] [Related]
23. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.
Chee WJY; Chew SY; Than LTL
Microb Cell Fact; 2020 Nov; 19(1):203. PubMed ID: 33160356
[TBL] [Abstract][Full Text] [Related]
24. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
Abad CL; Safdar N
J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
[TBL] [Abstract][Full Text] [Related]
25. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
Reid G; Charbonneau D; Erb J; Kochanowski B; Beuerman D; Poehner R; Bruce AW
FEMS Immunol Med Microbiol; 2003 Mar; 35(2):131-4. PubMed ID: 12628548
[TBL] [Abstract][Full Text] [Related]
26. Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora.
Strus M; Chmielarczyk A; Kochan P; Adamski P; Chełmicki Z; Chełmicki A; Pałucha A; Heczko PB
Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):210-5. PubMed ID: 22721635
[TBL] [Abstract][Full Text] [Related]
27. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
29. The influence of probiotics on the cervical malignancy diagnostics quality.
Perisić Z; Perisić N; Golocorbin Kon S; Vesović D; Jovanović AM; Mikov M
Vojnosanit Pregl; 2011 Nov; 68(11):956-60. PubMed ID: 22191313
[TBL] [Abstract][Full Text] [Related]
30. Effects of probiotics on the recurrence of bacterial vaginosis: a review.
Homayouni A; Bastani P; Ziyadi S; Mohammad-Alizadeh-Charandabi S; Ghalibaf M; Mortazavian AM; Mehrabany EV
J Low Genit Tract Dis; 2014 Jan; 18(1):79-86. PubMed ID: 24299970
[TBL] [Abstract][Full Text] [Related]
31. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
32. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli.
Cadieux PA; Burton J; Devillard E; Reid G
J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():13-8. PubMed ID: 20224146
[TBL] [Abstract][Full Text] [Related]
33. [Effect of Lactobacillus casei var rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis--randomized, open clinical trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():48-53. PubMed ID: 24294746
[TBL] [Abstract][Full Text] [Related]
34. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
[TBL] [Abstract][Full Text] [Related]
35. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms.
Saunders S; Bocking A; Challis J; Reid G
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):138-42. PubMed ID: 17234391
[TBL] [Abstract][Full Text] [Related]
36. Probiotics to prevent urinary tract infections: the rationale and evidence.
Reid G; Bruce AW
World J Urol; 2006 Feb; 24(1):28-32. PubMed ID: 16389539
[TBL] [Abstract][Full Text] [Related]
37. Probiotic agents to protect the urogenital tract against infection.
Reid G
Am J Clin Nutr; 2001 Feb; 73(2 Suppl):437S-443S. PubMed ID: 11157354
[TBL] [Abstract][Full Text] [Related]
38. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population.
Vaccalluzzo A; Pino A; Grimaldi RL; Caggia C; Cianci S; Randazzo CL
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38755019
[TBL] [Abstract][Full Text] [Related]
39. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of oral intake of
Sharpe M; Shah V; Freire-Lizama T; Cates EC; McGrath K; David I; Cowan S; Letkeman J; Stewart-Wilson E
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1814-1821. PubMed ID: 31362572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
